1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of diabetes and kidney stones
5.1.1.2. Rise in the awareness among people regarding urinary tract infections owing to rising healthcare expenditure
5.1.1.3. Emergence of portable and battery-operated urinary tract infections devices
5.1.2. Restraints
5.1.2.1. Complicated regulated monitoring
5.1.3. Opportunities
5.1.3.1. Increase in adoption of urinary tract infections in emerging economies
5.1.3.2. Rise in R&D of a novel class of antibiotics for urinary tract infections
5.1.4. Challenges
5.1.4.1. Complex clinical trials for designing antibacterial drugs that require an informative, ethical, and scientific approach
5.2. Cumulative Impact of COVID-19

6. Urinary Tract Infection Market, by Drug Class
6.1. Introduction
6.2. Aminoglycosides
6.3. Azoles
6.4. Quinolones
6.5. ?-lactam

7. Urinary Tract Infection Market, by Clinical Indication
7.1. Introduction
7.2. Cystitis
7.3. Pyelonephritis
7.4. Urethritis

8. Urinary Tract Infection Market, by End User
8.1. Introduction
8.2. Hospitals
8.3. Self-Administered

9. Americas Urinary Tract Infection Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Urinary Tract Infection Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand

11. Europe, Middle East & Africa Urinary Tract Infection Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. Allergan plc
13.2. AstraZeneca plc
13.3. Bayer AG
13.4. Boehringer Ingelheim GmbH
13.5. Cipla Inc.
13.6. Eli Lilly and Company,
13.7. F. Hoffmann La Roche Ltd
13.8. GlaxoSmithKline plc
13.9. Johnson & Johnson
13.10. Merck & Co. Inc.
13.11. Mindray Medical International Limited
13.12. Mylan N.V.
13.13. Novartis AG
13.14. Novo Nordisk A/S
13.15. Pfizer Inc.
13.16. Siemens Healthcare
13.17. Sun Pharmaceuticals Ltd.
13.18. Teva Pharmaceuticals
13.19. Urit Medical Electronic Group Co., Ltd.

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing

List of Figures

FIGURE 1. GLOBAL URINARY TRACT INFECTION MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL URINARY TRACT INFECTION MARKET: MARKET DYNAMICS
FIGURE 3. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY DRUG CLASS, 2020 VS 2027 (%)
FIGURE 4. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY DRUG CLASS, 2020 VS 2027 (USD MILLION)
FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY DRUG CLASS, 2027
FIGURE 6. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2027 (USD MILLION)
FIGURE 7. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY AMINOGLYCOSIDES, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 8. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY AZOLES, 2018-2027 (USD MILLION)
FIGURE 9. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY AZOLES, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 10. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY QUINOLONES, 2018-2027 (USD MILLION)
FIGURE 11. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY QUINOLONES, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 12. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY ?-LACTAM, 2018-2027 (USD MILLION)
FIGURE 13. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY ?-LACTAM, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 14. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2020 VS 2027 (%)
FIGURE 15. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2020 VS 2027 (USD MILLION)
FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2027
FIGURE 17. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY CYSTITIS, 2018-2027 (USD MILLION)
FIGURE 18. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY CYSTITIS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 19. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY PYELONEPHRITIS, 2018-2027 (USD MILLION)
FIGURE 20. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY PYELONEPHRITIS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 21. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY URETHRITIS, 2018-2027 (USD MILLION)
FIGURE 22. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY URETHRITIS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 23. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2020 VS 2027 (%)
FIGURE 24. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2020 VS 2027 (USD MILLION)
FIGURE 25. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2027
FIGURE 26. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY HOSPITALS, 2018-2027 (USD MILLION)
FIGURE 27. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 28. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY SELF-ADMINISTERED, 2018-2027 (USD MILLION)
FIGURE 29. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY SELF-ADMINISTERED, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 30. AMERICAS URINARY TRACT INFECTION MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 31. ARGENTINA URINARY TRACT INFECTION MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 32. BRAZIL URINARY TRACT INFECTION MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 33. CANADA URINARY TRACT INFECTION MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 34. MEXICO URINARY TRACT INFECTION MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 35. UNITED STATES URINARY TRACT INFECTION MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 36. ASIA-PACIFIC URINARY TRACT INFECTION MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 37. AUSTRALIA URINARY TRACT INFECTION MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 38. CHINA URINARY TRACT INFECTION MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 39. INDIA URINARY TRACT INFECTION MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 40. INDONESIA URINARY TRACT INFECTION MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 41. JAPAN URINARY TRACT INFECTION MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 42. MALAYSIA URINARY TRACT INFECTION MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 43. PHILIPPINES URINARY TRACT INFECTION MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 44. SINGAPORE URINARY TRACT INFECTION MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 45. SOUTH KOREA URINARY TRACT INFECTION MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 46. TAIWAN URINARY TRACT INFECTION MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 47. THAILAND URINARY TRACT INFECTION MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 48. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 49. FRANCE URINARY TRACT INFECTION MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 50. GERMANY URINARY TRACT INFECTION MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 51. ITALY URINARY TRACT INFECTION MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 52. NETHERLANDS URINARY TRACT INFECTION MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 53. QATAR URINARY TRACT INFECTION MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 54. RUSSIA URINARY TRACT INFECTION MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 55. SAUDI ARABIA URINARY TRACT INFECTION MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 56. SOUTH AFRICA URINARY TRACT INFECTION MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 57. SPAIN URINARY TRACT INFECTION MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 58. UNITED ARAB EMIRATES URINARY TRACT INFECTION MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 59. UNITED KINGDOM URINARY TRACT INFECTION MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 60. GLOBAL URINARY TRACT INFECTION MARKET: FPNV POSITIONING MATRIX
FIGURE 61. GLOBAL URINARY TRACT INFECTION MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 62. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL URINARY TRACT INFECTION MARKET, BY TYPE

List of Tables

TABLE 1. GLOBAL URINARY TRACT INFECTION MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 4. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY AMINOGLYCOSIDES, BY REGION, 2018-2027 (USD MILLION)
TABLE 5. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY AZOLES, BY REGION, 2018-2027 (USD MILLION)
TABLE 6. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY QUINOLONES, BY REGION, 2018-2027 (USD MILLION)
TABLE 7. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY ?-LACTAM, BY REGION, 2018-2027 (USD MILLION)
TABLE 8. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2027 (USD MILLION)
TABLE 9. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY CYSTITIS, BY REGION, 2018-2027 (USD MILLION)
TABLE 10. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY PYELONEPHRITIS, BY REGION, 2018-2027 (USD MILLION)
TABLE 11. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY URETHRITIS, BY REGION, 2018-2027 (USD MILLION)
TABLE 12. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 13. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2027 (USD MILLION)
TABLE 14. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY SELF-ADMINISTERED, BY REGION, 2018-2027 (USD MILLION)
TABLE 15. AMERICAS URINARY TRACT INFECTION MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 16. ARGENTINA URINARY TRACT INFECTION MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 17. BRAZIL URINARY TRACT INFECTION MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 18. CANADA URINARY TRACT INFECTION MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 19. MEXICO URINARY TRACT INFECTION MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 20. UNITED STATES URINARY TRACT INFECTION MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 21. ASIA-PACIFIC URINARY TRACT INFECTION MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 22. AUSTRALIA URINARY TRACT INFECTION MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 23. CHINA URINARY TRACT INFECTION MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 24. INDIA URINARY TRACT INFECTION MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 25. INDONESIA URINARY TRACT INFECTION MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 26. JAPAN URINARY TRACT INFECTION MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 27. MALAYSIA URINARY TRACT INFECTION MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 28. PHILIPPINES URINARY TRACT INFECTION MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 29. SINGAPORE URINARY TRACT INFECTION MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 30. SOUTH KOREA URINARY TRACT INFECTION MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 31. TAIWAN URINARY TRACT INFECTION MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 32. THAILAND URINARY TRACT INFECTION MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 33. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 34. FRANCE URINARY TRACT INFECTION MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 35. GERMANY URINARY TRACT INFECTION MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 36. ITALY URINARY TRACT INFECTION MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 37. NETHERLANDS URINARY TRACT INFECTION MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 38. QATAR URINARY TRACT INFECTION MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 39. RUSSIA URINARY TRACT INFECTION MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 40. SAUDI ARABIA URINARY TRACT INFECTION MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 41. SOUTH AFRICA URINARY TRACT INFECTION MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 42. SPAIN URINARY TRACT INFECTION MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 43. UNITED ARAB EMIRATES URINARY TRACT INFECTION MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 44. UNITED KINGDOM URINARY TRACT INFECTION MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 45. GLOBAL URINARY TRACT INFECTION MARKET: SCORES
TABLE 46. GLOBAL URINARY TRACT INFECTION MARKET: BUSINESS STRATEGY
TABLE 47. GLOBAL URINARY TRACT INFECTION MARKET: PRODUCT SATISFACTION
TABLE 48. GLOBAL URINARY TRACT INFECTION MARKET: RANKING
TABLE 49. GLOBAL URINARY TRACT INFECTION MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 50. GLOBAL URINARY TRACT INFECTION MARKET: MERGER & ACQUISITION
TABLE 51. GLOBAL URINARY TRACT INFECTION MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 52. GLOBAL URINARY TRACT INFECTION MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 53. GLOBAL URINARY TRACT INFECTION MARKET: INVESTMENT & FUNDING
TABLE 54. GLOBAL URINARY TRACT INFECTION MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 55. GLOBAL URINARY TRACT INFECTION MARKET: LICENSE & PRICING

Companies Mentioned

Allergan plc
AstraZeneca plc
Bayer AG
Boehringer Ingelheim GmbH
Cipla Inc.
Eli Lilly and Company,
F. Hoffmann La Roche Ltd
GlaxoSmithKline plc
Johnson & Johnson
Merck & Co. Inc.
Mindray Medical International Limited
Mylan N.V.
Novartis AG
Novo Nordisk A/S
Pfizer Inc.
Siemens Healthcare
Sun Pharmaceuticals Ltd.
Teva Pharmaceuticals
Urit Medical Electronic Group Co., Ltd.